| Literature DB >> 24721129 |
Yanhua Zhou1, Xiangwei Fu1, Guangbin Zhou2, Baoyu Jia1, Yi Fang1, Yunpeng Hou3, Shien Zhu1.
Abstract
BACKGROUND: At present, vitrification has been widely applied to humans, mice and farm animals. To improve the efficiency of vitrification in straw, bovine oocytes were used to test a new two-step vitrification method in this study.Entities:
Keywords: Bovine; Cryopreservation; Oocytes; Straw; Vitrification
Year: 2014 PMID: 24721129 PMCID: PMC4012761 DOI: 10.1186/2049-1891-5-19
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Figure 1Cubing protocol: the sucrose solution in the plug end occupies 5.0 cm, the section in which the oocytes are placed occupies 1.2 cm and a small volume of Gly50 lies to the right of the oocytes.
Figure 2Volume changes within bovine MII-stage oocytes during different CPA treatments. a) oocytes pre-treated with EG20 for 5 min and then transferred to pre-cooled EG40; b) oocytes pre-treated with EG20 for 5 min, transferred to pre-cooled (4°C) EG40 for 30 s, and then flushed with pre-cooled (4°C) Gly30; c) oocytes pre-treated with EG20 for 5 min, transferred to pre-cooled (4°C) EG40 for 30 s, and then flushed with pre-cooled (4°C) Gly40; d) oocytes pre-treated with EG20 for 5 min, transferred to pre-cooled (4°C) EG40 for 30 s, and then flushed with pre-cooled (4°C) Gly50; e) oocytes after pre-treatment with EG20 for 5 min and then transfer to pre-cooled Gly50.
Effects of oocyte vitrification on embryo development after parthenogenetic activation
| Control | 132 | 100% ± 0 (132/132)a | 84.21% ± 2% (111/132)a | 38.62% ± 0.75% (51/132)a |
| Toxicity | 103 | 93.22% ± 1.56% (96/103)b | 76.74% ± 2.27% (79/96)b | 35.93% ± 1.47% (37/96)a |
| Vitrified | 105 | 81.08% ± 2.86% (89/105)c | 63.49% ± 2.1% (66/105)c | 19.96% ± 1.06% (21/105)b |
Different superscripts (a, b, c) in the same column represent a significant difference (P < 0.05). Percentage data are presented as mean ± SEM.